title: [Insulin therapy during pregnancy: how far and how intensified?].
authors.affiliation: Service des Maladies endocriniennes, Hôpital Lapeyronie, Montpellier.
authors.forename: J
authors.initials: J
authors.lastname: Bringer
authors.forename: E
authors.initials: E
authors.lastname: Renard
authors.forename: M T
authors.initials: MT
authors.lastname: Baccara
authors.forename: P
authors.initials: P
authors.lastname: Boulot
authors.forename: N
authors.initials: N
authors.lastname: Jourdan
authors.forename: D
authors.initials: D
authors.lastname: Jacques-Apostol
authors.forename: C
authors.initials: C
authors.lastname: Jaffiol
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D016640:Diabetes, Gestational / Q000188:drug therapy; D005260:Female; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D007328:Insulin